Has consulted for Sangamo Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; sanofi-aventis; Novartis Pharmaceuticals Corporation (all compassionate use; unpaid); Foundation for the ...

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

Guaranteed success in drug development does not exist, such are the inherent risks, potential pitfalls and costs involved.

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...